HomeGLSI • NASDAQ
add
Greenwich Lifesciences Inc
Previous close
$9.72
Day range
$9.57 - $10.13
Year range
$8.06 - $15.47
Market cap
131.12M USD
Avg Volume
84.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.05M | 52.02% |
Net income | -4.03M | -54.42% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.05M | -52.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.13M | -56.75% |
Total assets | 3.13M | -56.77% |
Total liabilities | 1.69M | 24.58% |
Total equity | 1.44M | — |
Shares outstanding | 13.63M | — |
Price to book | 88.36 | — |
Return on assets | -344.28% | — |
Return on capital | -735.15% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -4.03M | -54.42% |
Cash from operations | -2.23M | -113.11% |
Cash from investing | — | — |
Cash from financing | 2.61M | -5.73% |
Net change in cash | 375.14K | -78.18% |
Free cash flow | -2.28M | -226.26% |
About
Founded
2006
Headquarters
Website
Employees
4